Characteristics of patients triaged in both groups
| TSS triage | RCS triage | Standardised differences | |
| n=1787 | n=793 | ||
| Mean (SD)/n (%) | |||
| Age (years) | 52.1 (16.0) | 52.5 (15.8) | 0.03 |
| Male (%) | 1653 (92.5) | 725 (91.4) | 0.04 |
| White (%) | 1256 (70.3) | 543 (68.5) | 0.04 |
| Hispanic (%) | 118 (6.6) | 58 (7.3) | 0.03 |
| BMI category (%) | |||
| <30 kg/m2 | 596 (33.4) | 273 (34.4) | 0.09 |
| 30–34.9 kg/m2 | 497 (27.8) | 193 (24.3) | |
| 35–39.9 kg/m2 | 257 (14.4) | 114 (14.4) | |
| ≥40 kg/m2 | 145 (8.1) | 67 (8.4) | |
| Missing BMI | 292 (16.3) | 146 (18.4) | |
| BMI (kg/m2)** | 32.0 (6.2) | 32.0 (6.5) | 0.00 |
| Hypertension (%) | 647 (36.2) | 265 (33.4) | 0.06 |
| Myocardial infarction (%) | 23 (1.3) | 16 (2.0) | 0.06 |
| Congestive heart failure (%) | 74 (4.1) | 36 (4.5) | 0.02 |
| Stroke (%) | 100 (5.6) | 42 (5.3) | 0.01 |
| Chronic lung disease (%) | 237 (13.3) | 85 (10.7) | 0.08 |
| Sleep disturbance NOS (%) | 100 (5.6) | 43 (5.4) | 0.01 |
| Restless leg syndrome (%) | 16 (0.9) | 7 (0.9) | 0.00 |
| Insomnia (%) | 195 (10.9) | 114 (14.4) | 0.10 |
| Atrial fibrillation (%) | 89 (5.0) | 39 (4.9) | 0.00 |
| Any opioid Rx (%) | 91 (5.1) | 36 (4.5) | 0.03 |
| Alpha blocker Rx (%) | 143 (8.0) | 61 (7.7) | 0.01 |
| PDE-5 inhibitor Rx (%) | 22 (1.2) | 7 (0.9) | 0.03 |
| Charlson score (points) | 1.9 (2.3) | 1.9 (2.3) | 0.02 |
| Drive time (min) | 55.6 (34.2) | 58.2 (34.1) | 0.08 |
BMI, body mass index; NOS, not otherwise specified; PDE-5, phosphodiesterase; RCS, referral coordination system; Rx, prescription; TSS, traditional specialist-led system.